REVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.

Clinical Epileptology, published by Springer Heidelberg, is an emerging open-access journal that aims to advance the understanding of epilepsy through rigorous research and clinical studies. With an ISSN of 2948-104X and E-ISSN of 2948-1058, this journal serves as a vital platform for researchers, clinicians, and students within the fields of Neurology, Pediatrics, and Perinatology. Although still in its formative years, spanning from 2023 to 2024, the journal aspires to fill the knowledge gaps in epilepsy research, thereby improving patient outcomes. Despite its initial Scopus rankings placing it within the 12th and 19th percentiles in respective categories, Clinical Epileptology is poised to make a significant impact by fostering interdisciplinary collaboration and disseminating high-quality findings. With options for open access, this journal ensures that groundbreaking research is readily available to a global audience, encouraging the ongoing dialogue that is crucial to advancing the field. Intended for a diverse readership, including academic researchers, healthcare professionals, and students, Clinical Epileptology is committed to becoming a cornerstone of epilepsy research.

Sleep and Breathing is a leading international journal published by SPRINGER HEIDELBERG, specializing in the fields of neurology and otorhinolaryngology. Since its inception in 1996, the journal has established itself as a pivotal resource for clinicians and researchers exploring the complex interactions between sleep and respiratory health. With an impressive Q2 ranking in Neurology (clinical) and a Q1 ranking in Otorhinolaryngology, it serves a diverse readership, offering a rich repository of original research, reviews, and clinical studies that address critical challenges in sleep medicine. The journal currently boasts a robust Scopus ranking, placing it among the top-tier publications in both specialties (Rank #16/123 in Otorhinolaryngology and Rank #140/400 in Clinical Neurology). While access options are limited, the high impact factor underscores its significance in shaping contemporary research dialogue. As such, Sleep and Breathing continues to be an essential platform for advancing knowledge and fostering collaboration within the nexus of sleep science and respiratory health.

EPILEPSIA is a premier academic journal published by Wiley, with a storied history dating back to 1909, making it a cornerstone in the field of epilepsy research and neurology. With an impressive impact factor reflecting its robust contribution to the academic community, EPILEPSIA is categorized in the top quartile (Q1) in both neurology and clinical neurology as of 2023, underscoring its significance and prestige. The journal is ranked #15 out of 192 in Neuroscience & Neurology and #34 out of 400 in Medicine & Neurology (clinical) within Scopus, indicating its essential role in advancing knowledge and treatments related to epilepsy. Researchers and clinicians are encouraged to contribute groundbreaking studies, case reports, and reviews that inform best practices and improve patient outcomes. Although EPILEPSIA currently does not offer open access options, its detailed exploration of both fundamental and clinical aspects of epilepsy ensures wide dissemination of crucial findings among professionals and students alike, furthering the understanding and management of this complex condition.

The INTERNATIONAL JOURNAL OF DERMATOLOGY, published by WILEY, stands as a premier scholarly platform in the field of dermatology, with a notable impact factor that affirms its quality and renown. Established in 1963 and converging through to 2024, this journal is recognized as a Q1 category publication, ranking in the top 20% of journals within the dermatology field according to the Scopus ranking system, where it occupies the 28th position among 142 journals. This reflects its dedication to advancing the understanding and treatment of skin diseases, making it a vital resource for researchers, healthcare professionals, and medical students alike. Although it does not provide open access options, articles published in this journal cover a broad range of dermatological topics, ensuring that it serves as a comprehensive and authoritative source for cutting-edge research and clinical practices. With its rigorous peer-review process and commitment to high standards, the INTERNATIONAL JOURNAL OF DERMATOLOGY remains indispensable for those engaged in dermatological science and practice.

WIENER KLINISCHE WOCHENSCHRIFT, published by SPRINGER WIEN, is a prestigious medical journal with a rich history dating back to 1946. With an ISSN of 0043-5325 and E-ISSN 1613-7671, it serves as a vital resource for researchers, healthcare professionals, and students engaged in the field of general medicine. The journal holds a commendable Q2 category ranking in Medicine (miscellaneous) and is positioned in the top 18% of its field according to Scopus, ranked #110 out of 636. Although it is not an open-access journal, it offers an essential platform for the dissemination of high-quality research, case studies, and clinical insights from Austria and beyond. The objectives of the journal include advancing medical knowledge, fostering collaborative research, and providing practitioners with the latest findings that inform clinical practice. This makes it an invaluable asset for anyone looking to stay at the forefront of medical research and development.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

CARDIOLOGY, published by KARGER, is a renowned scholarly journal dedicated to the advancement of research in the fields of cardiology and cardiovascular medicine. Since its inception in 1937, the journal has consistently provided a platform for high-quality, peer-reviewed articles that contribute to the understanding and treatment of heart and vascular diseases. With an impressive convergence through 2024, CARDIOLOGY holds a respectable Q2 ranking in both the Cardiology and Cardiovascular Medicine and Pharmacology (medical) categories, placing it within the 53rd and 45th percentiles of respective Scopus ranks. Based in Switzerland, the journal serves as an essential resource for researchers and practitioners aiming to stay abreast of cutting-edge developments and evidence-based practices in cardiovascular health. While it currently does not offer open access options, its commitment to rigorous scientific standards solidifies its significance within the academic community. We invite readers to explore the latest research findings and contribute to this vital field through publications in CARDIOLOGY.

Archives of Epilepsy is a pioneering academic journal dedicated to advancing the field of epilepsy research and clinical practice. Published by GALENOS PUBL HOUSE in Turkey, this Open Access journal has embraced the principle of unrestricted access since its inception in 2012, allowing researchers, healthcare professionals, and students from around the world to engage with cutting-edge findings in neuropathology. With a focus on clinical and neuroscience aspects of neurology, the journal occupies a significant position in the academic landscape, currently ranked in the Q4 quartile in both Neurology and Clinical Neurology categories as of 2023. Though it faces challenges in its Scopus rankings with a current percentile of 2nd in Medicine - Neurology (Clinical) and 1st in Neuroscience - Neurology, it offers a valuable platform for emerging studies. The journal's commitment to fostering a comprehensive understanding of epilepsy is crucial, as it facilitates broader discourse on effective treatments and patient care strategies. We invite researchers and practitioners to explore the impactful articles published in the Archives of Epilepsy and contribute to an evolving dialogue that strives to improve outcomes for individuals affected by epilepsy.

Clinical Obesity, published by WILEY, is a leading journal in the field of Endocrinology, Diabetes, and Metabolism that strives to advance the understanding of obesity-related health issues. With an ISSN of 1758-8103 and an E-ISSN of 1758-8111, this journal provides a platform for cutting-edge research and findings pertaining to the epidemiology, pathophysiology, prevention, and treatment of obesity. Recognized with a Q2 ranking in both Endocrinology, Diabetes and Metabolism and Medicine (miscellaneous) categories, and boasting a Scopus rank of #90 out of 244, Clinical Obesity encompasses innovative studies that influence clinical practice and public health policies. While this journal operates under a subscription model, its discipline-specific contributions are invaluable for researchers, healthcare professionals, and students keen on addressing the complexities of obesity in a comprehensive manner.